FMD - Phase 3 Shake
Natural health product licensed in Canada
- Licence holder
- Haylie Pomroy Group, Inc.
- NPN or DIN-HM
- 80083241
- Status
- Active licence
- Licence date
- 16 February 2018
- Revision date
- Not provided
- Form
- Poudre pour solution
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| trans-Resvératrol Source : Reynoutria Japonica - racine | 1.1565 mg | Not calculated |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Dimorphandra mollis - graine | 3.125 mg | Not calculated |
| Piper nigrum Source : Fruit Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 15.625 mg Potency : 95 % Piperine | 0.3125 mg | Not calculated |
| 4'-hydroxy-3,5-diméthoxystilbène Source : Pterostilbene | 0.969 mg | Not calculated |
| Sélénium Source : Methylselenocysteine | 0.9 mcg | Not calculated |
| Calcium Source : Saccharate de calcium | 15.625 mg | Not calculated |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 6.25 mg | Not calculated |
| Folate Source : Acide L-5 méthyltétrahydrofolique, sel de glucosamine | 12.5 mcg | Not calculated |
| Protéine de pois Source : Pisum sativum - Graine Potency : 59.36 % Protein | 10,119.05 mg | Not calculated |
| Linum usitatissimum Source : Linum usitatissimum - Graine | 3,500 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 1.024:1 Dry plant equivalent : 16 mg Potency : 6 % Caffeine | 15.625 mg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 6.25 mg | Not calculated |
| Silybum marianum Source : Silybum marianum - Graine Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 187.5 mg Potency : 80 % Silymarin | 6.25 mg | Not calculated |
| 3,3'-diindolylméthane Source : 3,3'-diindolylméthane | 4.6875 mg | Not calculated |
| Curcuma longa Source : Racine Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 156.25 mg Potency : 95 % Curcuminoids | 3.125 mg | Not calculated |
| (2R,3R)-3,3',4',5,7-Pentahydroxyflavanone Source : Larix dahurica - Bois | 0.2752 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 30 % Epigallocatechin 3-gallate | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 60 % Catechins | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 80 % Polyphenols | Not specified | Not calculated |
| Glucosinolate de 4-(méthylsulfinyl)butyle Source : Brassica oleracea var. italica (seed) | 0.9375 mg | Not calculated |
Non-medicinal ingredients
Silice, Triglycérides à chaîne moyenne, Saveur de vanille, Xylitol, Gomme de xanthane, Saveur, Huile de tournesol, Gomme de cellulose, Extrait de tiges/feuilles de Stevia rebaudiana
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Portion(s) | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Workout supplement. Athletic support. Source of protein for the maintenance of good health. Source of protein which helps build and repair body tissues. Source of amino acids involved in muscle protein synthesis. Assists in the building of lean muscle [tissue/mass] when combined with regular [weight/resistance] training and a healthy balanced diet. Source of/Provides antioxidants for the maintenance of good health. Source of antioxidants/Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effects of/the oxidative damage caused by/cell damage caused by) free radicals. An antioxidant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80083241
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.